CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.096
-0.024 (-1.12%)
Sep 11, 2026, 9:45 AM EDT - Market open
CalciMedica Market Cap
CalciMedica has a market cap or net worth of $14.31 million as of September 11, 2026. Its market cap has decreased by -66.85% in one year.
Market Cap
14.31M
Enterprise Value
4.90M
1-Year Change
-66.85%
Ranking
Category
Stock Price
$2.10
ChartMarket Cap Chart
Since March 21, 2023, CalciMedica's market cap has decreased from $92.48M to $14.31M, a decrease of -84.52%. That is a compound annual growth rate of -41.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 15.67M | -83.50% |
| Dec 31, 2025 | 94.96M | 98.97% |
| Dec 31, 2024 | 47.73M | 193.54% |
| Dec 29, 2023 | 16.26M | -82.42% |
| Mar 21, 2023 | 92.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 16.65M |
| PDS Biotechnology | 16.40M |
| Citius Pharmaceuticals | 15.98M |
| Passage Bio | 15.90M |
| Adial Pharmaceuticals | 15.57M |
| Moleculin Biotech | 14.90M |
| BioVie | 14.86M |
| NeuroSense Therapeutics | 14.83M |